News Could the BCG vaccine provide a cheap way of reversing type ... Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes.
News Oral insulin could still be a reality, says Novo Nordisk Last October Novo Nordisk announced that it had shelved plans to bring the world’s first oral insulin to market .
News Biotech vTv believes small molecule GLP-1 pill can take on b... Pill could be effective in diabetes, with fewer GI effects.
News J&J diabetes drug hit by amputation risk Invokana produces modest CV benefit, but doubles risk of amputation
Views & Analysis No overnight cure for type 1 diabetes - but closed loops off... But still little progress on finding preventive treatments.
News Insulet has a challenger for Medtronic on the Horizon System proven effective in children and adolescents as well as adults.
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.